Search Orphan Drug Designations and Approvals
-
Generic Name: | rexlemestrocel-L |
---|---|
Date Designated: | 02/14/2024 |
Orphan Designation: | Treatment of Hypoplastic Left Heart Syndrome |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Mesoblast, Inc. 505 Fifth Avenue Third Floor New York, New York 10017 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-